tiprankstipranks
Puma Biotechnology (PBYI)
NASDAQ:PBYI

Puma Biotechnology (PBYI) Stock Investors

569 Followers
Based on 728,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PBYI
On average, investors allocate 0.00% of their portfolios to PBYI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 728,786 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PBYI

0.1%
Last 7
Days
3.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PBYI, out of 728,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PBYI Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
1.16%
$5.54
Opened
0.00%
$5.58
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in PBYI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PBYI Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.13%
-0.04%
-0.41%
319.59B
Healthcare
ServiceNow
3.99%
-0.05%
-0.05%
150.84B
Technology
GE Aerospace
5.50%
+1.08%
+6.09%
168.04B
Industrials
Micron
5.83%
+0.36%
+23.55%
134.40B
Technology
Block
4.49%
-1.08%
-7.00%
45.25B
Technology
AbbVie
5.65%
+0.11%
-3.17%
286.26B
Healthcare
Trade Desk
4.70%
-0.79%
-2.40%
39.60B
Technology
Cisco Systems
4.55%
-0.81%
-5.21%
195.33B
Technology
Assertio Therapeutics
2.64%
-1.24%
-9.06%
77.36M
Healthcare
Boeing
5.87%
+0.35%
-0.59%
102.39B
Industrials
Based on the activity of 728,786 active portfolios
Open your Smart Portfolio

PBYI Investor Analysis

PBYI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.9%
of PBYI holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
PBYI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
44.4%
of PBYI holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
PBYI investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
46.7%
of PBYI holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of PBYI stock investors
See who invests in PBYI according to age group and performance.

FAQ

How many retail Investors hold PBYI?
<0.1% of TipRanks' retail investors hold PBYI in their portfolios.
    What is PBYI Investor Sentiment?
    PBYI’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of PBYI in the last 7 days?
      ▲ 0.1% of TipRanks' retail investors changed their holding of PBYI in the last 7 days.
        What percentage of retail investors changed their holding of PBYI in the last 30 days?
        ▲ 3.0% of TipRanks' retail investors changed their holding of PBYI in the last 30 days.
          What is the average age of retail investors who hold PBYI?
          The average age of PBYI Holders is over 55.
            What other stocks have PBYI investors also bought?
            PBYI Investors also bought MRK, NOW, GE, MU, SQ, ABBV, TTD, CSCO, ASRT, BA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis